Cargando…

Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative

[Image: see text] This report describes the development of an orally active analgesic that resolves inflammation and neuropathic pain without the addictive potential of opioids. EC5026 acts on the cytochrome P450 branch of the arachidonate cascade to stabilize epoxides of polyunsaturated fatty acids...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammock, Bruce D., McReynolds, Cindy B., Wagner, Karen, Buckpitt, Alan, Cortes-Puch, Irene, Croston, Glenn, Lee, Kin Sing Stephen, Yang, Jun, Schmidt, William K., Hwang, Sung Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917437/ https://www.ncbi.nlm.nih.gov/pubmed/33550801 http://dx.doi.org/10.1021/acs.jmedchem.0c01886

Ejemplares similares

Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development
por: McReynolds, Cindy B., et al.
Publicado: (2021)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019)

Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain
por: Takeshita, Ashley A., et al.
Publicado: (2023)

Inhibition of the Soluble Epoxide Hydrolase as an Analgesic Strategy: A Review of Preclinical Evidence
por: Wang, Yuxin, et al.
Publicado: (2021)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia
por: Tu, Ranran, et al.
Publicado: (2018)

Structure-guided discovery of potent and oral soluble epoxide hydrolase inhibitors for the treatment of neuropathic pain
por: Du, Fangyu, et al.
Publicado: (2022)

Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine
por: Shihadih, Diyala S., et al.
Publicado: (2020)

Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues
por: Morisseau, Christophe, et al.
Publicado: (2021)

The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling
por: Luo, Ailin, et al.
Publicado: (2023)

Author Correction: Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia
por: Tu, Ranran, et al.
Publicado: (2021)

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
por: Wan, Debin, et al.
Publicado: (2019)

Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase
por: Moghaddam, Mehran F., et al.
Publicado: (1997)

Soluble Epoxide Hydrolase Inhibition and Epoxyeicosatrienoic Acid Treatment Improve Vascularization of Engineered Skin Substitutes
por: Supp, Dorothy M., et al.
Publicado: (2016)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)

Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity
por: Oh, Young Taek, et al.
Publicado: (2023)

Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment
por: Zhu, Xiaoyu, et al.
Publicado: (2022)

Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice
por: Bettaieb, Ahmed, et al.
Publicado: (2014)

Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
por: Wagner, Karen M., et al.
Publicado: (2021)

Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice
por: Qin, Jun, et al.
Publicado: (2015)

Epoxy Fatty Acids and Inhibition of the Soluble Epoxide Hydrolase Selectively Modulate GABA Mediated Neurotransmission to Delay Onset of Seizures
por: Inceoglu, Bora, et al.
Publicado: (2013)

Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease
por: Jung, Oliver, et al.
Publicado: (2010)

Epoxide Hydrolases: Multipotential Biocatalysts
por: Bučko, Marek, et al.
Publicado: (2023)

Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales
por: Kitamura, Seiya, et al.
Publicado: (2017)

The Generation of a Nanobody-Based ELISA for Human Microsomal Epoxide Hydrolase
por: He, Qiyi, et al.
Publicado: (2023)

Dysregulation of Soluble Epoxide Hydrolase and Lipidomic Profiles in Anorexia Nervosa
por: Shih, Pei-an Betty, et al.
Publicado: (2015)

Soluble Epoxide Hydrolase Is Associated with Postprandial Anxiety Decrease in Healthy Adult Women
por: Nguyen, Nhien, et al.
Publicado: (2022)

Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy
por: Lee, Kin Sing Stephen, et al.
Publicado: (2014)

Opposite Effects of Gene Deficiency and Pharmacological Inhibition of Soluble Epoxide Hydrolase on Cardiac Fibrosis
por: Li, Lijuan, et al.
Publicado: (2014)

Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Diet-Induced Metabolic Syndrome in Rats
por: Iyer, Abishek, et al.
Publicado: (2012)

Role of the soluble epoxide hydrolase in the hair follicle stem cell homeostasis and hair growth
por: Naeem, Zumer, et al.
Publicado: (2022)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
por: Mello, Aline, et al.
Publicado: (2020)

Soluble Epoxide Hydrolase Contributes to Cell Senescence and ER Stress in Aging Mice Colon
por: Wang, Weicang, et al.
Publicado: (2023)

Correction to Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy
por: Lee, Kin Sing Stephen, et al.
Publicado: (2018)

Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022)

Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell‐based therapy
por: Sirish, Padmini, et al.
Publicado: (2020)

Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine
por: Wan, Xiayun, et al.
Publicado: (2020)

Aflatoxin B(1) Increases Soluble Epoxide Hydrolase in the Brain and Induces Neuroinflammation and Dopaminergic Neurotoxicity
por: Wang, Weicang, et al.
Publicado: (2023)

Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
por: Yang, Huiyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_65lvnejopktio1d7ohvtfqaoiq